Nintendo Wii Virtual Reality Application In Dementia
2 other identifiers
interventional
32
1 country
1
Brief Summary
•This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD. The aim of the present study is to investigate the effect of the virtual reality application on muscle strength and fall in individuals with Alzheimer' Dementia (AD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2019
CompletedFirst Submitted
Initial submission to the registry
March 10, 2021
CompletedFirst Posted
Study publicly available on registry
March 26, 2021
CompletedMarch 26, 2021
March 1, 2021
5 months
March 10, 2021
March 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Age :mean or median age
Age, Categorical: \>=65 years
period of 6 weeks
Body Mass Index
BMI was recorded in kg/m\^2.
period of 6 weeks
Sex/Gender
Sex: Female, Male
period of 6 weeks
Secondary Outcomes (1)
The Mini-Mental State Test for Cognitive status
period of 6 weeks
Study Arms (2)
Nintendo Wii Virtual Reality Application In Older People With Alzheimer's Dementia
EXPERIMENTALThe study included a total of 32 volunteers between the ages of 65-80, who stayed in Karaman Ahmet Mete Nursing Home, Elderly Care and Rehabilitation Center, with mild or moderate Alzheimer's dementia diagnosed by a neurologist. As a result of the power analysis, it was calculated that at least 16 individuals could be included in each group (at least 32 individuals in total). Randomization was performed by the sealed-envelope method. According to this method, 4 females and 12 males were determined to be in the control group, while 5 females and 11 males were determined to be in the training group. The evaluation was completed before the intervention. The same evaluation was conducted after 6 weeks. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes, and each patient was trained with the same games.
Older People With Alzheimer's Dementia
NO INTERVENTIONIn the control group, no application was performed during this period, and routine medical treatments were continued. The training group was evaluated before and after the training, while the control group was re-evaluated at the end of the 6th week after the first evaluation. After the study was completed, the volunteers from the control group were also given training.
Interventions
The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes.
Eligibility Criteria
You may qualify if:
- included volunteers between the ages of 65-80 with mild or moderate AD diagnosis,
- who did not have any difficulty or problems in communicating,
- who did not have any neurological diseases that disrupt balance and coordination such as a cerebrovascular event, Parkinson's disease, Multiple Sclerosis, and neurological disorder,
- who obtained a score of 18 - 24 points in the Mini-Mental State Test (MMST)
You may not qualify if:
- Patients diagnosed with rapidly progressing dementia (infection, vascular, hematologic diseases),
- Those who could not be contacted during the follow-up period or who did not participate in the training session, those who experienced cardiac and cerebrovascular events, endocrine disorders, fluid-electrolyte imbalance and infection,
- Those with malignancy and those who received chemotherapy and radiotherapy that causes malignancy, delirium or depression and malignant sensory loss (those with the Semmes-Weinstein monofilament thickness of 4.56 and above),
- Those with a lower or upper extremity amputation at any level
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karaman Ahmet Mete Nursing Home
Konya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Konya Karaman Ahmet Mete Nursing Home
Karaman Ahmet Mete Nursing Home. Konya in Turkey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Kırıkkale University
Study Record Dates
First Submitted
March 10, 2021
First Posted
March 26, 2021
Study Start
January 15, 2018
Primary Completion
June 6, 2018
Study Completion
January 15, 2019
Last Updated
March 26, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share